365 WMG Private Fund I: Primus Fund LLC’s AbbVie ABBV Stock Holding History

365 WMG Private Fund I: Primus Fund LLC’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$506K	Buy	+1,935	New	+$496K	0.3%	59

Other funds holding ABBV

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Cardano Risk Management Rotterdam, Netherlands $18.2B AUM 38.97% 1-Year Est. Return

Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return

ABN AMRO Investment Solutions Paris Cedex 008 $13.2B AUM 30.55% 1-Year Est. Return

MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return

Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return

Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return

365 WMG Private Fund I: Primus Fund LLC's ABBV Position: Q3 2026 in Review

365 WMG Private Fund I: Primus Fund LLC opened a new position in AbbVie (ABBV) in Q3 2026: 1,935 shares worth $506K. The stake represents 0.3% of the portfolio and ranks #59 among its holdings.

1,139 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

365 WMG Private Fund I: Primus Fund LLC held 1,935 shares of AbbVie worth $506K as of Q3 2026.
AbbVie was a new 365 WMG Private Fund I: Primus Fund LLC position in Q3 2026.
AbbVie made up 0.3% of 365 WMG Private Fund I: Primus Fund LLC's portfolio in Q3 2026, its #59 holding.
1,139 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on 365 WMG Private Fund I: Primus Fund LLC's 13F filing for Q3 2026, filed 20 Oct 2026.